Quantum Biopharma Ltd QNTM

$2.44 +0.07 (2.95%)

Valuation

Market cap
19,167,000
Revenue TTM
$0
Net income TTM
$-26,180,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
52,600
Avg volume
162,268
Day's range
$2.35 – $2.50
Shares out
8,087,000
Stochastic %K
76%
Beta
0.39
Analysts
Strong Sell
Price target
$21.75

Price

Company profile

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of de...

Show more

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company's lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is based in Toronto, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
833-304-0323
Website
https://www.quantumbiopharma.com
Address
1 Adelaide Street East, Suite 801, Toronto, Canada

Latest news

Stocktwits

FickleFin Oct 28, 2:29 PM
$QNTM the other fucktard stealing retail money... Anthony Durkacz. (The banker) the mastermind behind the loopholes. The mouse storyline has been used repeatedly since 2022. You can see all this information is nothing new. Just revamped and regurgitated for years with a different face. You can tell he's offsetting the truth in the podcast. Using a soft caring tone followed by facts and a cough (clearing throat) to offset the ones invested. 100% a Shitco. https://youtu.be/jC-sogbR7iE?si=tp_CNWLkljUmMjio
0 replies
Grumbly Oct 28, 11:50 AM
$QNTM shit company should go bk.
0 replies
FickleFin Oct 28, 11:49 AM
$QNTM <--- FUCK YOU to RETAIL INVESTORS. SAEED the CEO LOOKS and ACTS like a THIEF. Just like the last CEO RAZA. All they ever do is steal from retail investors. Now with the name change, board shuffle, votes minimized, shell sold, pawns placed. Shitco is getting ready for a bailout run. $GNS $GME $QNTM $BNKK
0 replies
FickleFin Oct 27, 1:36 PM
$QNTM $GNS $GME $QNTM $BNKK
0 replies
GNSretailpiggybank Oct 26, 8:43 PM
$GNS hey guys. I’ve got a great idea, let’s keep using the catch phrase of the “fiduciary “ that bagged all of his clients with $QNTM and $GNS! Malone put the FUD and the douche in fiduciary. Absolute clown college! LMAO! 🤣🤣🤣🥕🥕🥕
3 replies
gloryb Oct 26, 7:15 PM
$QNTM fucking crooks
0 replies
Cons228 Oct 26, 2:26 PM
$GNS $QNTM stocks don’t smell … Whatever you smell, it must be you!
0 replies
buzik Oct 23, 8:51 AM
$QNTM
0 replies